A phase II study of erlotinib and bevacizumab in patients with locally advanced and/or metastatic (stage IIIB or IV) non-small cell lung cancer who have not received prior chemotherapy

2013 ◽  
Author(s):  
H J M Groen
Lung Cancer ◽  
2008 ◽  
Vol 60 (3) ◽  
pp. 374-380 ◽  
Author(s):  
Christian Peschel ◽  
Joerg T. Hartmann ◽  
Alexander Schmittel ◽  
Carsten Bokemeyer ◽  
Folker Schneller ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document